FDA sets date to review Boston Scientific stent

AuntMinnie.com staff writers
Sep 15, 2003

The Food and Drug Administration will hold a special panel hearing on November 20 to review Boston Scientific’s premarket approval (PMA) application for the Taxus Express2 paclitaxel-eluting coronary stent. The Natick, MA-based interventional device developer said it presented the fifth and final module of the product’s PMA to the FDA this June, an action that marked the beginning of the official regulatory review process for the device.

By AuntMinnie.com staff writers
September 16, 2003

Related Reading

Boston Scientific releases Taxus clinical results, September 16, 2003

Boston Scientific’s Taxus stent receives Canadian approval, September 12, 2003

Boston Scientific, CryoVascular form alliance, September 11, 2003

Boston Scientific adds to IVUS offerings, August 14, 2003

Boston Scientific seeks stock split, July 30, 2003

Copyright © 2003 AuntMinnie.com

Latest in Interventional
Emergency 400
Ultrasound-guided nerve blocks safe for emergency pain management
November 13, 2024
Thyroid Cancer
Thermal ablation effective long term in patients with thyroid cancer
November 7, 2024
Lawsuit 6511c4190f4c2
Mass. radiology provider may be liable for 'unavailable' IR physician
October 28, 2024
Knee
GAE could be cost-effective for knee osteoarthritis
September 26, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2003 06 06 15 35 19 706
Interventional
Interventional rads put faith in UFE marketing, research despite skepticism of ob/gyns
2003 03 31 16 13 26 706
Interventional
Uterine fibroid embolization does not impair fertility
2003 02 22 14 18 17 706
Interventional
PICCing sides: Interventional radiologists weigh IV access lines
More in Interventional
Ultrasound-guided nerve blocks safe for emergency pain management
By Amerigo Allegretto
Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.
November 13, 2024
Emergency 400
Thermal ablation effective long term in patients with thyroid cancer
By Will Morton
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.
November 7, 2024
Thyroid Cancer
Mass. radiology provider may be liable for 'unavailable' IR physician
By Kate Madden Yee
The Massachusetts Court of Appeals has ruled that a radiology services provider could be held liable for failing to provide a patient with access to an on-call interventional radiologist.
October 28, 2024
Lawsuit 6511c4190f4c2
GAE could be cost-effective for knee osteoarthritis
By Will Morton
Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.
September 26, 2024
Knee
PAE mitigates enlarged prostate symptoms after 2 years
By Will Morton
Men with enlarged prostates who undergo minimally invasive prostatic artery embolization (PAE) have significant improvements in symptoms after two years.
September 5, 2024
Prostate Imaging
Acute stroke intervention results in long-term benefits
By Will Morton
The benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up.
August 26, 2024
Stroke Evt
Should there be an age limit for performing EVT in stroke patients?
By Will Morton
Could a fixed upper age limit be justified for performing endovascular thrombectomies (EVT) to treat the oldest elderly stroke patients?
August 12, 2024
Evt
Cryoneurolysis effective for pain control after rib fractures
By Will Morton
CT-guided cryoneurolysis – the freezing of nerves to alleviate pain – is safe and effective in older adults with rib fractures.
August 7, 2024
I Rs2
Cryoablation safe, effective in treating soft-tissue sarcoma
By Amerigo Allegretto
Percutaneous cryoablation is safe and effective for patients with recurrent or metastatic soft-tissue sarcoma after earlier treatments.
August 1, 2024
(A) Axial noncontrast CT chest image shows soft tissue mass in the anterior chest wall (arrow). The lesion was treated by percutaneous cryoablation. (B) Intraprocedural axial CT image obtained during cryoablation. The pink outline represents the target lesion and the blue outline represents ice ball. Based on review, the procedure was classified as achieving adequate ablation. (C) Axial contrast-enhanced CT chest image, obtained three months after ablation (patient’s first follow-up exam), shows involution of the target lesion without evidence of residue. Image courtesy of the ARRS.
A few interventional radiologists get lion's share of industry payments
By Erik L. Ridley
A very small percentage of interventional radiologists are benefitting the most from industry payments.
July 24, 2024
Dollars Pile
Cryoablation safe and effective for treating breast cancer
By Amerigo Allegretto
Cryoablation is a safe, effective treatment method for breast cancer, new research suggests.
July 11, 2024
Breast Cancer 3 D
Many women unaware of treatment options for uterine fibroids
By Amerigo Allegretto
Over 50% of women diagnosed with uterine fibroids have been offered hysterectomy, while fewer than 20% are presented with other options.
July 9, 2024
Uterus Pelvic Social
Page 1 of 181
Next Page